The FDA sent
warning letters to 14 companies about sponsored links whose text did not sufficiently disclose the risks of the advertised drugs. A useful reminder that background principles of law--not just crazy extensions of trademark law--apply to sponsored links. I found notable the comment from an FDA spokesperson that the FDA hadn't contacted Google and other search engines because "its policy is not to contact third parties that carry drug ads, even if they violate agency rules." Section 230 might also have something to say about that!
What about fraud in labs claiming to do GLP animal work when in fact if is subcontracted? Or when the advertising labs lacks the experience and people to conduct GLP studies? Can anything be done about this or should it be done?
ReplyDelete